Author:
Rennard Stephen,Bantje Theo,Centanni Stefano,Chanez Pascal,Chuchalin Alexander,D’Urzo Anthony,Kornmann Oliver,Perry Sheryl,Jack Damon,Owen Roger,Higgins Mark
Subject
Pulmonary and Respiratory Medicine
Reference30 articles.
1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung, and Blood Institute. April 2001: updated September 2005. GOLD website 〈www.gold.copd.com〉, accessed 22 September 2006.
2. Management of chronic obstructive pulmonary disease;Sutherland;N Engl J Med,2004
3. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease;Dahl;Am J Respir Crit Care Med,2001
4. Formoterol in Chronic Obstructive Pulmonary Disease (FICOPD) II Study Group. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD;Rossi;Chest,2002
5. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease;Rennard;Am J Respir Crit Care Med,2001
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献